The OIG is reviewing who pays for drugs during Part A stays. See your exposure in 48 hours →

Generic substitution in nursing homes: where savings start

Generic substitution and therapeutic interchange in nursing homes: how each works, who decides, and how to find pharmacy savings on facility-paid drugs.

Get a free 48-hour audit Estimate your savings

Generic substitution can produce real nursing home pharmacy savings because generic drugs usually cost far less than brands, and for facility-paid Part A drugs every dollar saved stays with the facility. Generic substitution swaps a brand for an FDA-rated therapeutically equivalent generic of the same drug. Therapeutic interchange swaps one drug for a different drug in the same class, and needs prescriber authorization under a protocol the facility's clinical leadership approves.

What is generic substitution?

Generic substitution is dispensing an approved generic in place of the brand-name drug that was prescribed. The generic contains the same active ingredient in the same strength, dosage form and route.

The FDA's Orange Book, formally Approved Drug Products with Therapeutic Equivalence Evaluations, lists which products are interchangeable. According to the Orange Book preface, drugs are therapeutic equivalents when they are pharmaceutical equivalents with demonstrated bioequivalence and "can be expected to have the same clinical effect and safety profile" when used as labeled.

Each product carries a therapeutic equivalence (TE) code:

  • "A" codes (AA, AB, AN, AO, AP, AT) mean FDA considers the product therapeutically equivalent to other pharmaceutically equivalent products. AB means a potential bioequivalence question was resolved with evidence.
  • "B" codes mean FDA does not currently consider the product therapeutically equivalent.

State law governs when a pharmacist may substitute. The Orange Book notes that virtually every state has laws that encourage substitution. It also notes that a prescriber may require a specific product as a medical necessity.

What is therapeutic interchange?

Therapeutic interchange is replacing a prescribed drug with a different drug, with a different active ingredient, that is expected to have a similar therapeutic effect. Examples are switching between drugs within the same class.

This is not generic substitution. The Orange Book does not rate drugs with different active ingredients as equivalent. Therapeutic interchange is a clinical decision that requires the prescriber's authorization, usually under a written protocol.

Generic substitutionTherapeutic interchange
Active ingredientSameDifferent
ReferenceFDA Orange Book TE codeClinical evidence and facility protocol
Who authorizesPharmacist, within state law, unless prescriber requires the brandPrescriber, under a protocol approved through the facility's clinical process
Typical savings sourceBrand to generic price gapHigher-cost to lower-cost drug in the class
Finance team's roleFind brand lines with an A-rated generic; verify billingSupply cost data to the clinical review

Who decides on substitution in a nursing home?

Clinical decisions belong to clinicians. In a nursing home, three parties are involved.

  • The prescriber writes and changes orders. No cost program overrides the prescriber's judgment for a resident.
  • The consultant pharmacist reviews each resident's drug regimen at least monthly and reports irregularities to the attending physician, medical director and director of nursing (42 CFR 483.45(c)). The physician must document review of each irregularity and any action taken.
  • The facility's pharmacy and therapeutics (P&T) process, usually involving the medical director, director of nursing and consultant pharmacist, sets policies such as a formulary or interchange protocol.

Finance and administration support this process with data. They do not run it.

What could your building recover?

Two numbers, instant estimate. No email needed.

Estimated recoverable per year$0
See your full estimate Planning estimate for one building at 85% occupancy. How it works

Why does generic substitution save money?

Generics usually cost far less than brands, and the gap grows as more manufacturers make the drug. CMS's NADAC Equivalency Metrics for the quarter ending September 2026 show how acquisition cost compares with list prices:

Generic drugs by number of manufacturers (labelers)Median NADAC below WACMedian NADAC below AWP
117.9%42.2%
237.2%61.4%
347.3%77.0%
556.0%88.8%
11 or more57.0%97.1%

NADAC (National Average Drug Acquisition Cost) is CMS's survey of what retail pharmacies pay. Our explainer on AWP, WAC and NADAC covers the three benchmarks. The point here is simple: a common generic can cost a small fraction of the list price, and a small fraction of the brand.

Whether you capture that depends on two things. Is the generic actually dispensed? And does your contract price generics fairly? A generic billed at a high AWP-based price recovers only part of the saving.

Where do the savings sit for the facility?

The facility pays directly for drugs during a covered Part A stay, because drugs are inside Medicare's bundled payment under SNF consolidated billing. Our guide to who pays for drugs during a Part A stay explains the split.

For Part D residents, the plan's formulary drives brand and generic choices, and the saving goes to the plan and the resident. For Medicaid residents, state rules apply. So the facility's direct cost interest is concentrated in Part A and in any managed care contract where the facility pays for drugs. That makes short-stay and rehab-heavy facilities the most exposed.

How do you find generic substitution opportunities?

  1. Pull facility-paid lines. Filter the invoice to Part A and other facility-paid payer codes. Our guide to reading an LTC pharmacy invoice shows the fields.
  2. Flag brand NDCs. Mark each line where the National Drug Code is a brand product.
  3. Check for an A-rated generic. Look up the drug in the Orange Book for an approved, A-rated generic in the same strength and dosage form.
  4. Check the order. Note any order marked brand medically necessary. Those lines are not opportunities.
  5. Rank by dollars. Sort remaining lines by spend. A short list usually covers most of the value.
  6. Check generic pricing. For generics already dispensed, compare the unit price with NADAC and your contract's generic formula.
  7. Send the list to the clinical team. Give the consultant pharmacist and medical director the list with costs. They decide what, if anything, changes.
  8. Track the result on invoices. Confirm that agreed changes show up as generic NDCs at contract price in the following months.

For therapeutic interchange, the finance team's job ends at step 7. Supply cost comparisons for the classes where the facility spends most, and let the P&T process decide whether an interchange protocol is appropriate.

Free · 48 hours · no integration

Get a free 48-hour pharmacy audit

  • Send three files: invoices, census, contract
  • See overbilling and Part A exposure, line by line
  • BAA signed before any data moves

What should your pharmacy contract say about generics?

Look for a generic pricing formula with a visible MAC list (maximum allowable cost, the pharmacy's generic price list), a "lesser of" rule, and a commitment to dispense A-rated generics where permitted unless the prescriber requires the brand. Our article on pharmacy services agreement terms covers the clause in more detail.

This article is general information, not clinical or legal advice. Substitution and interchange decisions belong to the prescriber, the consultant pharmacist and the facility's P&T process.

Frequently asked questions

Are generic drugs as effective as brand-name drugs?

The FDA rates a generic as therapeutically equivalent when it is pharmaceutically equivalent and bioequivalent to the brand and can be expected to have the same clinical effect and safety profile. The Orange Book lists those ratings. Clinical questions for a specific resident belong to the prescriber and pharmacist.

What is the difference between generic substitution and therapeutic interchange?

Generic substitution swaps a brand for a generic of the same drug. Therapeutic interchange swaps one drug for a different drug in the same class, and requires the prescriber's authorization, usually under a facility protocol.

Can a nursing home require generic substitution?

A facility can adopt policies and formulary practices through its clinical leadership, within state pharmacy law. The prescriber can still require a specific brand when medically necessary. Policy design belongs to the medical director, consultant pharmacist and P&T process.

Who benefits from generic savings in a nursing home?

For residents in a covered Part A stay, the facility pays for drugs, so the facility keeps the saving. For Part D and Medicaid residents, the plan or state program pays, so the saving accrues mainly to them and to the resident.

Get the 48-hour first look

Send three months of invoices, your census and your pharmacy services agreement. We flag facility-paid brand lines with an A-rated generic and generics priced above the contract, ready for your clinical team to review, within 48 hours. Request the free 48-hour audit or try the savings calculator.